Bionano interim CEO Albert Luderer buys $4,845 of common shares

• Bionano Genomics interim Chief Executive Albert Luderer reported an indirect purchase of 4,000 common shares at $1.21.
• Holdings reported as 8,000 shares following the transaction, held in a Traditional IRA.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bionano Genomics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001746822-26-000005), on September 09, 2026, and is solely responsible for the information contained therein.